Contribution of tumor endothelial cells to drug resistance: anti-angiogenic tyrosine kinase inhibitors act as p-glycoprotein antagonists. [electronic resource]
- Angiogenesis May 2017
- 233-241 p. digital
Publication Type: Journal Article
1573-7209
10.1007/s10456-017-9549-6 doi
3T3 Cells ATP Binding Cassette Transporter, Subfamily B--antagonists & inhibitors Angiogenesis Inhibitors--pharmacology Animals Doxorubicin--pharmacology Drug Resistance, Neoplasm--drug effects Human Umbilical Vein Endothelial Cells--metabolism Humans Mice Mice, Nude Neoplasm Proteins--antagonists & inhibitors Neoplasms--blood supply Protein Kinase Inhibitors--pharmacology Xenograft Model Antitumor Assays